| Protective effect of berberine on serum glucose levels in non-obese diabetic mice. | |
| | |
MedLine Citation:
|
PMID: 22266065 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Among the active components in traditional anti-diabetic herbal plants, berberine which is an isoquinoline alkaloid exhibits promising potential for its potent anti-inflammatory and hypoglycemic effects. However, the berberine effect on serum glucose levels in type 1 diabetes (T1D) subjects still remains unknown. This study investigated berberine's effects on serum glucose levels using non-obese diabetic (NOD) mice that spontaneously develop T1D. The NOD mice were randomly divided into four groups, administered water with 50, 150, and 500mg berberine/kg bw, respectively, through 14weeks. ICR mice were also selected as a species control group to compare with the NOD mice. Changes in body weight, oral glucose challenge, and serum glucose levels were determined to identify the protective effect of berberine on T1D. After the 14-week oral supplementation, berberine decreased fasting serum glucose levels in NOD mice close to the levels in normal ICR mice in a dose dependent manner. Serum berberine levels showed a significantly (P<0.05) negative and non-linear correlation with fasting glucose levels in berberine-administered NOD mice. Our results suggested that berberine supplemented at appropriate doses for 14weeks did not cause toxic side effects, but improved hyperglycemia in NOD mice. |
| | |
Authors:
|
Wei-Han Chueh; Jin-Yuarn Lin |
Related Documents
:
|
11940045 - Elevation of soluble e-selectin levels following gestational diabetes is restricted to ... 20059445 - The hyperglycemia and adverse pregnancy outcome (hapo) study: can we use the results as... 1423545 - The effects of established and gestational diabetes on pregnancy outcome at harare mate... 3528695 - Diabetes and pregnancy: control can make a difference. 11775565 - Glucose disposal in morbidly obese patients in the early post-operative period. 8918685 - Sequestration of centrally administered insulin by the brain: effects of starvation, al... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-17 |
Journal Detail:
|
Title: International immunopharmacology Volume: - ISSN: 1878-1705 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100965259 Medline TA: Int Immunopharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012. Published by Elsevier B.V. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Performance of two 17 locus forensic identification STR kits-Applied Biosystems's AmpF?STR(®) NGMSE...
Next Document: Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE-antigen complex-s...